ID   CD166_HUMAN             Reviewed;         583 AA.
AC   Q13740; B2RNS3; B4DTU0; O60892; Q1HGM8; Q1HGM9; Q6PEY4; Q6ZS95;
DT   01-NOV-1997, integrated into UniProtKB/Swiss-Prot.
DT   28-NOV-2006, sequence version 2.
DT   07-APR-2021, entry version 194.
DE   RecName: Full=CD166 antigen;
DE   AltName: Full=Activated leukocyte cell adhesion molecule;
DE   AltName: CD_antigen=CD166;
DE   Flags: Precursor;
GN   Name=ALCAM; Synonyms=MEMD {ECO:0000303|PubMed:9502422};
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT MET-301, PARTIAL PROTEIN
RP   SEQUENCE, INTERACTION WITH CD6, SUBUNIT, SUBCELLULAR LOCATION, FUNCTION,
RP   AND TISSUE SPECIFICITY.
RX   PubMed=7760007; DOI=10.1084/jem.181.6.2213;
RA   Bowen M.A., Patel D.D., Li X., Modrell B., Malacko A.R., Wang W.-C.,
RA   Marquardt H., Neubauer M., Pesando J.M., Francke U., Haynes B.F.,
RA   Aruffo A.;
RT   "Cloning, mapping, and characterization of activated leukocyte-cell
RT   adhesion molecule (ALCAM), a CD6 ligand.";
RL   J. Exp. Med. 181:2213-2220(1995).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 3),
RP   FUNCTION (ISOFORMS 1 AND 3), GLYCOSYLATION, AND TISSUE SPECIFICITY.
RX   PubMed=15496415; DOI=10.1074/jbc.m407776200;
RA   Ikeda K., Quertermous T.;
RT   "Molecular isolation and characterization of a soluble isoform of activated
RT   leukocyte cell adhesion molecule that modulates endothelial cell
RT   function.";
RL   J. Biol. Chem. 279:55315-55323(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORMS 1 AND 2).
RA   Abe Y., Bui-Thanh N.-A., Smith C.W., Ballantyne C.M., Burns A.R.;
RT   "A novel alternatively spliced variant of activated leukocyte cell adhesion
RT   molecule (ALCAM/CD166) resulting from a deletion in the extracellular
RT   membrane proximal stem.";
RL   Submitted (APR-2006) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=16641997; DOI=10.1038/nature04728;
RA   Muzny D.M., Scherer S.E., Kaul R., Wang J., Yu J., Sudbrak R., Buhay C.J.,
RA   Chen R., Cree A., Ding Y., Dugan-Rocha S., Gill R., Gunaratne P.,
RA   Harris R.A., Hawes A.C., Hernandez J., Hodgson A.V., Hume J., Jackson A.,
RA   Khan Z.M., Kovar-Smith C., Lewis L.R., Lozado R.J., Metzker M.L.,
RA   Milosavljevic A., Miner G.R., Morgan M.B., Nazareth L.V., Scott G.,
RA   Sodergren E., Song X.-Z., Steffen D., Wei S., Wheeler D.A., Wright M.W.,
RA   Worley K.C., Yuan Y., Zhang Z., Adams C.Q., Ansari-Lari M.A., Ayele M.,
RA   Brown M.J., Chen G., Chen Z., Clendenning J., Clerc-Blankenburg K.P.,
RA   Chen R., Chen Z., Davis C., Delgado O., Dinh H.H., Dong W., Draper H.,
RA   Ernst S., Fu G., Gonzalez-Garay M.L., Garcia D.K., Gillett W., Gu J.,
RA   Hao B., Haugen E., Havlak P., He X., Hennig S., Hu S., Huang W.,
RA   Jackson L.R., Jacob L.S., Kelly S.H., Kube M., Levy R., Li Z., Liu B.,
RA   Liu J., Liu W., Lu J., Maheshwari M., Nguyen B.-V., Okwuonu G.O.,
RA   Palmeiri A., Pasternak S., Perez L.M., Phelps K.A., Plopper F.J., Qiang B.,
RA   Raymond C., Rodriguez R., Saenphimmachak C., Santibanez J., Shen H.,
RA   Shen Y., Subramanian S., Tabor P.E., Verduzco D., Waldron L., Wang J.,
RA   Wang J., Wang Q., Williams G.A., Wong G.K.-S., Yao Z., Zhang J., Zhang X.,
RA   Zhao G., Zhou J., Zhou Y., Nelson D., Lehrach H., Reinhardt R.,
RA   Naylor S.L., Yang H., Olson M., Weinstock G., Gibbs R.A.;
RT   "The DNA sequence, annotation and analysis of human chromosome 3.";
RL   Nature 440:1194-1198(2006).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 2 AND 4).
RC   TISSUE=Lung, and Placenta;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A., Sudo H.,
RA   Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M., Takahashi M.,
RA   Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y., Abe K., Kamihara K.,
RA   Katsuta N., Sato K., Tanikawa M., Yamazaki M., Ninomiya K., Ishibashi T.,
RA   Yamashita H., Murakawa K., Fujimori K., Tanai H., Kimata M., Watanabe M.,
RA   Hiraoka S., Chiba Y., Ishida S., Ono Y., Takiguchi S., Watanabe S.,
RA   Yosida M., Hotuta T., Kusano J., Kanehori K., Takahashi-Fujii A., Hara H.,
RA   Tanase T.-O., Nomura Y., Togiya S., Komai F., Hara R., Takeuchi K.,
RA   Arita M., Imose N., Musashino K., Yuuki H., Oshima A., Sasaki N.,
RA   Aotsuka S., Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y., Fujimori Y.,
RA   Komiyama M., Tashiro H., Tanigami A., Fujiwara T., Ono T., Yamada K.,
RA   Fujii Y., Ozaki K., Hirao M., Ohmori Y., Kawabata A., Hikiji T.,
RA   Kobatake N., Inagaki H., Ikema Y., Okamoto S., Okitani R., Kawakami T.,
RA   Noguchi S., Itoh T., Shigeta K., Senba T., Matsumura K., Nakajima Y.,
RA   Mizuno T., Morinaga M., Sasaki M., Togashi T., Oyama M., Hata H.,
RA   Watanabe M., Komatsu T., Mizushima-Sugano J., Satoh T., Shirai Y.,
RA   Takahashi Y., Nakagawa K., Okumura K., Nagase T., Nomura N., Kikuchi H.,
RA   Masuho Y., Yamashita R., Nakai K., Yada T., Nakamura Y., Ohara O.,
RA   Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 3).
RC   TISSUE=Brain, and Lung;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 2-583 (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=9502422;
RA   Degen W.G., van Kempen L.C., Gijzen E.G., van Groningen J.J., van Kooyk Y.,
RA   Bloemers H.P.J., Swart G.W.;
RT   "MEMD, a new cell adhesion molecule in metastasizing human melanoma cell
RT   lines, is identical to ALCAM (activated leukocyte cell adhesion
RT   molecule).";
RL   Am. J. Pathol. 152:805-813(1998).
RN   [8]
RP   DOMAIN CD6 BINDING, AND INTERACTION WITH CD6.
RX   PubMed=8823162; DOI=10.1021/bi961038k;
RA   Skonier J.E., Bowen M.A., Emswiler J., Aruffo A., Bajorath J.;
RT   "Recognition of diverse proteins by members of the immunoglobulin
RT   superfamily: delineation of the receptor binding site in the human CD6
RT   ligand ALCAM.";
RL   Biochemistry 35:12287-12291(1996).
RN   [9]
RP   GLYCOSYLATION AT ASN-91; ASN-167; ASN-480 AND ASN-499.
RX   PubMed=12754519; DOI=10.1038/nbt827;
RA   Zhang H., Li X.-J., Martin D.B., Aebersold R.;
RT   "Identification and quantification of N-linked glycoproteins using
RT   hydrazide chemistry, stable isotope labeling and mass spectrometry.";
RL   Nat. Biotechnol. 21:660-666(2003).
RN   [10]
RP   FUNCTION, INTERACTION WITH CD6, SUBUNIT, SUBCELLULAR LOCATION, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=15048703; DOI=10.1002/eji.200424856;
RA   Hassan N.J., Barclay A.N., Brown M.H.;
RT   "Frontline: Optimal T cell activation requires the engagement of CD6 and
RT   CD166.";
RL   Eur. J. Immunol. 34:930-940(2004).
RN   [11]
RP   SUBCELLULAR LOCATION.
RX   PubMed=15294938; DOI=10.4049/jimmunol.173.4.2262;
RA   Gimferrer I., Calvo M., Mittelbrunn M., Farnos M., Sarrias M.R., Enrich C.,
RA   Vives J., Sanchez-Madrid F., Lozano F.;
RT   "Relevance of CD6-mediated interactions in T cell activation and
RT   proliferation.";
RL   J. Immunol. 173:2262-2270(2004).
RN   [12]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-95; ASN-265 AND ASN-499.
RC   TISSUE=Plasma;
RX   PubMed=16335952; DOI=10.1021/pr0502065;
RA   Liu T., Qian W.-J., Gritsenko M.A., Camp D.G. II, Monroe M.E., Moore R.J.,
RA   Smith R.D.;
RT   "Human plasma N-glycoproteome analysis by immunoaffinity subtraction,
RT   hydrazide chemistry, and mass spectrometry.";
RL   J. Proteome Res. 4:2070-2080(2005).
RN   [13]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH CD6, SUBUNIT, AND TISSUE
RP   SPECIFICITY.
RX   PubMed=16352806; DOI=10.1182/blood-2005-09-3881;
RA   Zimmerman A.W., Joosten B., Torensma R., Parnes J.R., van Leeuwen F.N.,
RA   Figdor C.G.;
RT   "Long-term engagement of CD6 and ALCAM is essential for T-cell
RT   proliferation induced by dendritic cells.";
RL   Blood 107:3212-3220(2006).
RN   [14]
RP   INTERACTION WITH CD6.
RX   PubMed=16914752; DOI=10.1128/mcb.00688-06;
RA   Hassan N.J., Simmonds S.J., Clarkson N.G., Hanrahan S., Puklavec M.J.,
RA   Bomb M., Barclay A.N., Brown M.H.;
RT   "CD6 regulates T-cell responses through activation-dependent recruitment of
RT   the positive regulator SLP-76.";
RL   Mol. Cell. Biol. 26:6727-6738(2006).
RN   [15]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-91; ASN-95; ASN-457 AND
RP   ASN-480.
RC   TISSUE=Liver;
RX   PubMed=19159218; DOI=10.1021/pr8008012;
RA   Chen R., Jiang X., Sun D., Han G., Wang F., Ye M., Wang L., Zou H.;
RT   "Glycoproteomics analysis of human liver tissue by combination of multiple
RT   enzyme digestion and hydrazide chemistry.";
RL   J. Proteome Res. 8:651-661(2009).
RN   [16]
RP   GLYCOSYLATION [LARGE SCALE ANALYSIS] AT ASN-457.
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19349973; DOI=10.1038/nbt.1532;
RA   Wollscheid B., Bausch-Fluck D., Henderson C., O'Brien R., Bibel M.,
RA   Schiess R., Aebersold R., Watts J.D.;
RT   "Mass-spectrometric identification and relative quantification of N-linked
RT   cell surface glycoproteins.";
RL   Nat. Biotechnol. 27:378-386(2009).
RN   [17]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T.,
RA   Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [18]
RP   FUNCTION, TISSUE SPECIFICITY, SUBCELLULAR LOCATION, AND INDUCTION BY TNF
RP   AND IFNG.
RX   PubMed=23169771; DOI=10.1096/fj.12-217844;
RA   Iolyeva M., Karaman S., Willrodt A.H., Weingartner S., Vigl B., Halin C.;
RT   "Novel role for ALCAM in lymphatic network formation and function.";
RL   FASEB J. 27:978-990(2013).
RN   [19]
RP   FUNCTION, TISSUE SPECIFICITY, AND SUBCELLULAR LOCATION.
RX   PubMed=24740813; DOI=10.1182/blood-2014-03-565721;
RA   Chitteti B.R., Kobayashi M., Cheng Y., Zhang H., Poteat B.A.,
RA   Broxmeyer H.E., Pelus L.M., Hanenberg H., Zollman A., Kamocka M.M.,
RA   Carlesso N., Cardoso A.A., Kacena M.A., Srour E.F.;
RT   "CD166 regulates human and murine hematopoietic stem cells and the
RT   hematopoietic niche.";
RL   Blood 124:519-529(2014).
RN   [20]
RP   INTERACTION WITH CD6; LGALS1 AND LGALS3, GLYCOSYLATION, FUNCTION, AND
RP   SUBCELLULAR LOCATION.
RX   PubMed=24945728; DOI=10.1016/j.febslet.2014.05.064;
RA   Escoda-Ferran C., Carrasco E., Caballero-Banos M., Miro-Julia C.,
RA   Martinez-Florensa M., Consuegra-Fernandez M., Martinez V.G., Liu F.T.,
RA   Lozano F.;
RT   "Modulation of CD6 function through interaction with galectin-1 and -3.";
RL   FEBS Lett. 588:2805-2813(2014).
RN   [21]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D., Wang L.,
RA   Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human liver
RT   phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [22]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=25944712; DOI=10.1002/pmic.201400617;
RA   Vaca Jacome A.S., Rabilloud T., Schaeffer-Reiss C., Rompais M., Ayoub D.,
RA   Lane L., Bairoch A., Van Dorsselaer A., Carapito C.;
RT   "N-terminome analysis of the human mitochondrial proteome.";
RL   Proteomics 15:2519-2524(2015).
RN   [23]
RP   3D-STRUCTURE MODELING OF 28-133.
RX   PubMed=8520490; DOI=10.1002/pro.5560040822;
RA   Bajorath J., Bowen M.A., Aruffo A.;
RT   "Molecular model of the N-terminal receptor-binding domain of the human CD6
RT   ligand ALCAM.";
RL   Protein Sci. 4:1644-1647(1995).
RN   [24]
RP   X-RAY CRYSTALLOGRAPHY (1.86 ANGSTROMS), DISULFIDE BONDS, INTERACTION WITH
RP   CD6, AND SUBUNIT.
RX   PubMed=26146185; DOI=10.1016/j.str.2015.05.019;
RA   Chappell P.E., Garner L.I., Yan J., Metcalfe C., Hatherley D., Johnson S.,
RA   Robinson C.V., Lea S.M., Brown M.H.;
RT   "Structures of CD6 and its ligand CD166 give insight into their
RT   interaction.";
RL   Structure 23:1426-1436(2015).
CC   -!- FUNCTION: Cell adhesion molecule that mediates both heterotypic cell-
CC       cell contacts via its interaction with CD6, as well as homotypic cell-
CC       cell contacts (PubMed:7760007, PubMed:15496415, PubMed:15048703,
CC       PubMed:16352806, PubMed:23169771, PubMed:24945728). Promotes T-cell
CC       activation and proliferation via its interactions with CD6
CC       (PubMed:15048703, PubMed:16352806, PubMed:24945728). Contributes to the
CC       formation and maturation of the immunological synapse via its
CC       interactions with CD6 (PubMed:15294938, PubMed:16352806). Mediates
CC       homotypic interactions with cells that express ALCAM (PubMed:15496415,
CC       PubMed:16352806). Required for normal hematopoietic stem cell
CC       engraftment in the bone marrow (PubMed:24740813). Mediates attachment
CC       of dendritic cells onto endothelial cells via homotypic interaction
CC       (PubMed:23169771). Inhibits endothelial cell migration and promotes
CC       endothelial tube formation via homotypic interactions (PubMed:15496415,
CC       PubMed:23169771). Required for normal organization of the lymph vessel
CC       network. Required for normal hematopoietic stem cell engraftment in the
CC       bone marrow. Plays a role in hematopoiesis; required for normal numbers
CC       of hematopoietic stem cells in bone marrow. Promotes in vitro
CC       osteoblast proliferation and differentiation (By similarity). Promotes
CC       neurite extension, axon growth and axon guidance; axons grow
CC       preferentially on surfaces that contain ALCAM. Mediates outgrowth and
CC       pathfinding for retinal ganglion cell axons (By similarity).
CC       {ECO:0000250|UniProtKB:P42292, ECO:0000269|PubMed:15048703,
CC       ECO:0000269|PubMed:15294938, ECO:0000269|PubMed:15496415,
CC       ECO:0000269|PubMed:16352806, ECO:0000269|PubMed:24945728,
CC       ECO:0000269|PubMed:7760007}.
CC   -!- FUNCTION: [Isoform 3]: Inhibits activities of membrane-bound isoforms
CC       by competing for the same interaction partners. Inhibits cell
CC       attachment via homotypic interactions. Promotes endothelial cell
CC       migration. Inhibits endothelial cell tube formation.
CC       {ECO:0000269|PubMed:15496415}.
CC   -!- SUBUNIT: Homodimer (PubMed:7760007, PubMed:16352806, PubMed:15048703,
CC       PubMed:26146185). Interacts (via extracellular domain) with CD6 (via
CC       extracellular domain) (PubMed:7760007, PubMed:8823162, PubMed:15048703,
CC       PubMed:16914752, PubMed:24945728, PubMed:26146185). Homodimerization
CC       and interaction with CD6 involve the same region and cannot occur
CC       simultaneously. The affinity for CD6 is much higher than the affinity
CC       for self-association (PubMed:15048703). Interacts (via glycosylated
CC       extracellular domain) with LGALS1 and LGALS3 (PubMed:24945728).
CC       Interaction with LGALS1 or LGALS3 inhibits interaction with CD6
CC       (PubMed:24945728). {ECO:0000269|PubMed:15048703,
CC       ECO:0000269|PubMed:16352806, ECO:0000269|PubMed:16914752,
CC       ECO:0000269|PubMed:24945728, ECO:0000269|PubMed:26146185,
CC       ECO:0000269|PubMed:7760007, ECO:0000269|PubMed:8823162}.
CC   -!- INTERACTION:
CC       Q13740; Q13740: ALCAM; NbExp=3; IntAct=EBI-1188108, EBI-1188108;
CC       Q13740; P30203: CD6; NbExp=5; IntAct=EBI-1188108, EBI-2873748;
CC       Q13740; P09382: LGALS1; NbExp=3; IntAct=EBI-1188108, EBI-1048875;
CC       Q13740; P17931: LGALS3; NbExp=3; IntAct=EBI-1188108, EBI-1170392;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:15048703,
CC       ECO:0000269|PubMed:15294938, ECO:0000269|PubMed:16352806,
CC       ECO:0000269|PubMed:23169771, ECO:0000269|PubMed:24740813,
CC       ECO:0000269|PubMed:24945728, ECO:0000269|PubMed:7760007}; Single-pass
CC       type I membrane protein {ECO:0000305}. Cell projection, axon
CC       {ECO:0000250|UniProtKB:Q61490}. Cell projection, dendrite
CC       {ECO:0000250|UniProtKB:Q61490}. Note=Detected at the immunological
CC       synapse, i.e, at the contact zone between antigen-presenting dendritic
CC       cells and T-cells (PubMed:15294938, PubMed:16352806). Colocalizes with
CC       CD6 and the TCR/CD3 complex at the immunological synapse
CC       (PubMed:15294938). {ECO:0000269|PubMed:15294938,
CC       ECO:0000269|PubMed:16352806}.
CC   -!- SUBCELLULAR LOCATION: [Isoform 3]: Secreted
CC       {ECO:0000269|PubMed:15496415}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=4;
CC       Name=1;
CC         IsoId=Q13740-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13740-2; Sequence=VSP_021797;
CC       Name=3; Synonyms=sALCAM;
CC         IsoId=Q13740-3; Sequence=VSP_053530, VSP_053531;
CC       Name=4;
CC         IsoId=Q13740-4; Sequence=VSP_053529, VSP_053532;
CC   -!- TISSUE SPECIFICITY: Detected on hematopoietic stem cells derived from
CC       umbilical cord blood (PubMed:24740813). Detected on lymph vessel
CC       endothelial cells, skin and tonsil (PubMed:23169771). Detected on
CC       peripheral blood monocytes (PubMed:15048703). Detected on monocyte-
CC       derived dendritic cells (at protein level) (PubMed:16352806). Detected
CC       at low levels in spleen, placenta, liver (PubMed:9502422). Expressed by
CC       activated T-cells, B-cells, monocytes and thymic epithelial cells
CC       (PubMed:7760007). Isoform 1 and isoform 3 are detected in vein and
CC       artery endothelial cells, astrocytes, keratinocytes and artery smooth
CC       muscle cells (PubMed:15496415). Expressed by neurons in the brain.
CC       Restricted expression in tumor cell lines. Detected in highly
CC       metastasizing melanoma cell lines (PubMed:9502422).
CC       {ECO:0000269|PubMed:15048703, ECO:0000269|PubMed:24740813,
CC       ECO:0000269|PubMed:7760007, ECO:0000269|PubMed:9502422}.
CC   -!- INDUCTION: Up-regulated by TNF and IFNG (at protein level).
CC       {ECO:0000269|PubMed:23169771}.
CC   -!- DOMAIN: The CD6 binding site is located in the N-terminal Ig-like
CC       domain. {ECO:0000269|PubMed:8823162}.
CC   -!- PTM: Glycosylated. {ECO:0000269|PubMed:15496415,
CC       ECO:0000305|PubMed:24945728}.
CC   -!- MISCELLANEOUS: [Isoform 3]: Secreted form, inhibits isoform 1
CC       homophilic interaction. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; L38608; AAB59499.1; -; mRNA.
DR   EMBL; AY644765; AAV28819.1; -; mRNA.
DR   EMBL; DQ486139; ABF48405.1; -; mRNA.
DR   EMBL; DQ486140; ABF48406.1; -; mRNA.
DR   EMBL; AK127617; BAC87059.1; -; mRNA.
DR   EMBL; AK300362; BAG62102.1; -; mRNA.
DR   EMBL; AK316113; BAH14484.1; -; mRNA.
DR   EMBL; AC023602; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC078806; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC133476; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC057809; AAH57809.1; -; mRNA.
DR   EMBL; BC137096; AAI37097.1; -; mRNA.
DR   EMBL; BC137097; AAI37098.1; -; mRNA.
DR   EMBL; Y10183; CAA71256.1; -; mRNA.
DR   CCDS; CCDS33810.1; -. [Q13740-1]
DR   CCDS; CCDS58841.1; -. [Q13740-2]
DR   PIR; I39428; I39428.
DR   RefSeq; NP_001230209.1; NM_001243280.1. [Q13740-2]
DR   RefSeq; NP_001230212.1; NM_001243283.1. [Q13740-3]
DR   RefSeq; NP_001618.2; NM_001627.3. [Q13740-1]
DR   PDB; 1KJC; Model; -; A=28-133.
DR   PDB; 5A2F; X-ray; 1.86 A; A=1-583.
DR   PDBsum; 1KJC; -.
DR   PDBsum; 5A2F; -.
DR   SMR; Q13740; -.
DR   BioGRID; 106716; 35.
DR   DIP; DIP-39093N; -.
DR   IntAct; Q13740; 18.
DR   MINT; Q13740; -.
DR   STRING; 9606.ENSP00000305988; -.
DR   TCDB; 8.A.23.1.10; the basigin (basigin) family.
DR   GlyConnect; 1085; 66 N-Linked glycans (8 sites).
DR   GlyGen; Q13740; 10 sites, 8 N-linked glycans (5 sites).
DR   iPTMnet; Q13740; -.
DR   MetOSite; Q13740; -.
DR   PhosphoSitePlus; Q13740; -.
DR   SwissPalm; Q13740; -.
DR   BioMuta; ALCAM; -.
DR   DMDM; 118572629; -.
DR   CPTAC; CPTAC-1502; -.
DR   CPTAC; CPTAC-1503; -.
DR   EPD; Q13740; -.
DR   jPOST; Q13740; -.
DR   MassIVE; Q13740; -.
DR   MaxQB; Q13740; -.
DR   PaxDb; Q13740; -.
DR   PeptideAtlas; Q13740; -.
DR   PRIDE; Q13740; -.
DR   ProteomicsDB; 5128; -.
DR   ProteomicsDB; 59670; -. [Q13740-1]
DR   ProteomicsDB; 59671; -. [Q13740-2]
DR   ProteomicsDB; 68208; -.
DR   ABCD; Q13740; 25 sequenced antibodies.
DR   Antibodypedia; 2625; 801 antibodies.
DR   Ensembl; ENST00000306107; ENSP00000305988; ENSG00000170017. [Q13740-1]
DR   Ensembl; ENST00000472644; ENSP00000419236; ENSG00000170017. [Q13740-2]
DR   GeneID; 214; -.
DR   KEGG; hsa:214; -.
DR   UCSC; uc003dvx.4; human. [Q13740-1]
DR   CTD; 214; -.
DR   DisGeNET; 214; -.
DR   GeneCards; ALCAM; -.
DR   HGNC; HGNC:400; ALCAM.
DR   HPA; ENSG00000170017; Tissue enhanced (parathyroid).
DR   MIM; 601662; gene.
DR   neXtProt; NX_Q13740; -.
DR   OpenTargets; ENSG00000170017; -.
DR   PharmGKB; PA24691; -.
DR   VEuPathDB; HostDB:ENSG00000170017.12; -.
DR   eggNOG; ENOG502RMQM; Eukaryota.
DR   GeneTree; ENSGT00940000156881; -.
DR   InParanoid; Q13740; -.
DR   OMA; YPEGNIT; -.
DR   OrthoDB; 536204at2759; -.
DR   PhylomeDB; Q13740; -.
DR   TreeFam; TF321859; -.
DR   PathwayCommons; Q13740; -.
DR   Reactome; R-HSA-373760; L1CAM interactions.
DR   SIGNOR; Q13740; -.
DR   BioGRID-ORCS; 214; 6 hits in 1000 CRISPR screens.
DR   ChiTaRS; ALCAM; human.
DR   GeneWiki; ALCAM; -.
DR   GenomeRNAi; 214; -.
DR   Pharos; Q13740; Tbio.
DR   PRO; PR:Q13740; -.
DR   Proteomes; UP000005640; Chromosome 3.
DR   RNAct; Q13740; protein.
DR   Bgee; ENSG00000170017; Expressed in oviduct epithelium and 237 other tissues.
DR   ExpressionAtlas; Q13740; baseline and differential.
DR   Genevisible; Q13740; HS.
DR   GO; GO:0030424; C:axon; ISS:UniProtKB.
DR   GO; GO:0030425; C:dendrite; IEA:UniProtKB-SubCell.
DR   GO; GO:0009897; C:external side of plasma membrane; IEA:Ensembl.
DR   GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB.
DR   GO; GO:0005925; C:focal adhesion; HDA:UniProtKB.
DR   GO; GO:0001772; C:immunological synapse; IDA:UniProtKB.
DR   GO; GO:0005887; C:integral component of plasma membrane; ISS:UniProtKB.
DR   GO; GO:0031226; C:intrinsic component of plasma membrane; IDA:UniProtKB.
DR   GO; GO:0043025; C:neuronal cell body; IEA:Ensembl.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0005102; F:signaling receptor binding; TAS:ProtInc.
DR   GO; GO:0002250; P:adaptive immune response; IEA:UniProtKB-KW.
DR   GO; GO:0048846; P:axon extension involved in axon guidance; ISS:UniProtKB.
DR   GO; GO:0007155; P:cell adhesion; ISS:UniProtKB.
DR   GO; GO:0007157; P:heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules; IMP:UniProtKB.
DR   GO; GO:0008045; P:motor neuron axon guidance; IEA:Ensembl.
DR   GO; GO:1990138; P:neuron projection extension; ISS:UniProtKB.
DR   GO; GO:0031290; P:retinal ganglion cell axon guidance; ISS:UniProtKB.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   DisProt; DP02515; -.
DR   Gene3D; 2.60.40.10; -; 5.
DR   InterPro; IPR039810; CD166_antigen.
DR   InterPro; IPR013162; CD80_C2-set.
DR   InterPro; IPR007110; Ig-like_dom.
DR   InterPro; IPR036179; Ig-like_dom_sf.
DR   InterPro; IPR013783; Ig-like_fold.
DR   InterPro; IPR003599; Ig_sub.
DR   InterPro; IPR003598; Ig_sub2.
DR   InterPro; IPR013106; Ig_V-set.
DR   PANTHER; PTHR11973:SF2; PTHR11973:SF2; 1.
DR   Pfam; PF08205; C2-set_2; 1.
DR   SMART; SM00409; IG; 3.
DR   SMART; SM00408; IGc2; 3.
DR   SMART; SM00406; IGv; 1.
DR   SUPFAM; SSF48726; SSF48726; 5.
DR   PROSITE; PS50835; IG_LIKE; 4.
PE   1: Evidence at protein level;
KW   3D-structure; Adaptive immunity; Alternative splicing; Cell adhesion;
KW   Cell membrane; Cell projection; Direct protein sequencing; Disulfide bond;
KW   Glycoprotein; Immunity; Immunoglobulin domain; Membrane;
KW   Reference proteome; Repeat; Secreted; Signal; Transmembrane;
KW   Transmembrane helix.
FT   SIGNAL          1..27
FT                   /evidence="ECO:0000255"
FT   CHAIN           28..583
FT                   /note="CD166 antigen"
FT                   /id="PRO_0000014659"
FT   TOPO_DOM        28..527
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        528..549
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TOPO_DOM        550..583
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000255"
FT   DOMAIN          28..120
FT                   /note="Ig-like V-type 1"
FT   DOMAIN          125..234
FT                   /note="Ig-like V-type 2"
FT   DOMAIN          245..328
FT                   /note="Ig-like C2-type 1"
FT   DOMAIN          333..409
FT                   /note="Ig-like C2-type 2"
FT   DOMAIN          416..501
FT                   /note="Ig-like C2-type 3"
FT   CARBOHYD        91
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        95
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        167
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519"
FT   CARBOHYD        265
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:16335952"
FT   CARBOHYD        306
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        361
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   CARBOHYD        457
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:19159218,
FT                   ECO:0000269|PubMed:19349973"
FT   CARBOHYD        480
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:19159218"
FT   CARBOHYD        499
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000269|PubMed:12754519,
FT                   ECO:0000269|PubMed:16335952"
FT   DISULFID        43..113
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0007744|PDB:5A2F"
FT   DISULFID        157..220
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114,
FT                   ECO:0007744|PDB:5A2F"
FT   DISULFID        270..313
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        354..392
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   DISULFID        435..485
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
FT   VAR_SEQ         1..191
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053529"
FT   VAR_SEQ         132..133
FT                   /note="KQ -> SK (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15496415"
FT                   /id="VSP_053530"
FT   VAR_SEQ         134..583
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:15489334,
FT                   ECO:0000303|PubMed:15496415"
FT                   /id="VSP_053531"
FT   VAR_SEQ         244..330
FT                   /note="Missing (in isoform 4)"
FT                   /evidence="ECO:0000303|PubMed:14702039"
FT                   /id="VSP_053532"
FT   VAR_SEQ         503..516
FT                   /note="ISIPEHDEADEISD -> N (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:14702039, ECO:0000303|Ref.3"
FT                   /id="VSP_021797"
FT   VARIANT         229
FT                   /note="G -> D (in dbSNP:rs10933819)"
FT                   /id="VAR_029514"
FT   VARIANT         258
FT                   /note="N -> S (in dbSNP:rs1044240)"
FT                   /id="VAR_003907"
FT   VARIANT         301
FT                   /note="T -> M (in dbSNP:rs1044243)"
FT                   /evidence="ECO:0000269|PubMed:7760007"
FT                   /id="VAR_003908"
FT   VARIANT         315
FT                   /note="L -> M (in dbSNP:rs12629872)"
FT                   /id="VAR_029515"
FT   VARIANT         352
FT                   /note="V -> M (in dbSNP:rs2291375)"
FT                   /id="VAR_029516"
FT   VARIANT         367
FT                   /note="M -> I (in dbSNP:rs34926152)"
FT                   /id="VAR_049856"
FT   STRAND          30..34
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          39..41
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          51..59
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          65..72
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   TURN            73..75
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          78..80
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   HELIX           84..86
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   TURN            87..89
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          90..92
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          98..102
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   HELIX           105..107
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          109..117
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          120..132
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          138..141
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          144..148
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          152..164
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          167..172
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   TURN            181..183
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          184..192
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   TURN            194..196
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          199..207
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   HELIX           211..213
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          218..226
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          229..234
FT                   /evidence="ECO:0007744|PDB:5A2F"
FT   STRAND          241..243
FT                   /evidence="ECO:0007744|PDB:5A2F"
SQ   SEQUENCE   583 AA;  65102 MW;  68FEFD67C14B0C57 CRC64;
     MESKGASSCR LLFCLLISAT VFRPGLGWYT VNSAYGDTII IPCRLDVPQN LMFGKWKYEK
     PDGSPVFIAF RSSTKKSVQY DDVPEYKDRL NLSENYTLSI SNARISDEKR FVCMLVTEDN
     VFEAPTIVKV FKQPSKPEIV SKALFLETEQ LKKLGDCISE DSYPDGNITW YRNGKVLHPL
     EGAVVIIFKK EMDPVTQLYT MTSTLEYKTT KADIQMPFTC SVTYYGPSGQ KTIHSEQAVF
     DIYYPTEQVT IQVLPPKNAI KEGDNITLKC LGNGNPPPEE FLFYLPGQPE GIRSSNTYTL
     TDVRRNATGD YKCSLIDKKS MIASTAITVH YLDLSLNPSG EVTRQIGDAL PVSCTISASR
     NATVVWMKDN IRLRSSPSFS SLHYQDAGNY VCETALQEVE GLKKRESLTL IVEGKPQIKM
     TKKTDPSGLS KTIICHVEGF PKPAIQWTIT GSGSVINQTE ESPYINGRYY SKIIISPEEN
     VTLTCTAENQ LERTVNSLNV SAISIPEHDE ADEISDENRE KVNDQAKLIV GIVVGLLLAA
     LVAGVVYWLY MKKSKTASKH VNKDLGNMEE NKKLEENNHK TEA
//
